Production (Stage)
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.74
-$0.09-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.29M | -40.21M | -38.70M | -34.97M | -33.76M |
| Total Depreciation and Amortization | 517.30K | 588.30K | 602.30K | 603.30K | 611.10K |
| Total Amortization of Deferred Charges | 208.30K | 396.30K | 586.30K | 714.30K | 810.90K |
| Total Other Non-Cash Items | 4.40M | 3.01M | 2.69M | 1.74M | 2.20M |
| Change in Net Operating Assets | -5.09M | -5.58M | -2.04M | 1.82M | 1.18M |
| Cash from Operations | -50.25M | -41.79M | -36.86M | -30.09M | -28.95M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.95M | -121.31M | -119.65M | -93.39M | -68.14M |
| Cash from Investing | -4.95M | -121.31M | -119.65M | -93.39M | -68.14M |
| Total Debt Issued | -- | -- | 373.00K | 373.00K | 373.00K |
| Total Debt Repaid | -13.16M | -15.48M | -17.68M | -7.53M | -5.41M |
| Issuance of Common Stock | 66.48M | 175.38M | 175.38M | 139.44M | 109.07M |
| Repurchase of Common Stock | -13.00K | -13.00K | -74.00K | -154.00K | -154.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.69M | 6.69M | 6.69M | 6.69M | -- |
| Cash from Financing | 60.00M | 166.58M | 164.69M | 138.82M | 103.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.80M | 3.47M | 8.17M | 15.34M | 6.78M |